A dual specificity kinase, DYRK1A, as a potential therapeutic target for head and neck squamous cell carcinoma

Despite advances in clinical management, 5-year survival rate in patients with late-stage head and neck squamous cell carcinoma (HNSCC) has not improved significantly over the past decade. Targeted therapies have emerged as one of the most promising approaches to treat several malignancies. Though t...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Τόπος έκδοσης:Sci Rep
Κύριοι συγγραφείς: Radhakrishnan, Aneesha, Nanjappa, Vishalakshi, Raja, Remya, Sathe, Gajanan, Puttamallesh, Vinuth N., Jain, Ankit P., Pinto, Sneha M., Balaji, Sai A., Chavan, Sandip, Sahasrabuddhe, Nandini A., Mathur, Premendu P., Kumar, Mahesh M., Prasad, T. S. Keshava, Santosh, Vani, Sukumar, Geethanjali, Califano, Joseph A., Rangarajan, Annapoorni, Sidransky, David, Pandey, Akhilesh, Gowda, Harsha, Chatterjee, Aditi
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: Nature Publishing Group 2016
Θέματα:
Article
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5086852/
https://ncbi.nlm.nih.gov/pubmed/27796319
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/srep36132
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια